Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice.

Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice.

Item
http://www.wikidata.org/entity/Q33924909
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.Recurrence of atrial fibrillation after switching from brand to generic atenololGeneric Substitution Issues: Brand-generic Substitution, Generic-generic Substitution, and Generic Substitution of Narrow Therapeutic Index (NTI)/Critical Dose Drugs.Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.Safety and efficacy of generic drugs with respect to brand formulation.Does the FDA Owe Us an Explanation?Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients."Appropriate Treatment" and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units.
P2860

Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice.

Item
http://www.wikidata.org/entity/Q33924909
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Formulation substitution and o ...... d safety in clinical practice.
@ast
Formulation substitution and o ...... d safety in clinical practice.
@en
type
label
Formulation substitution and o ...... d safety in clinical practice.
@ast
Formulation substitution and o ...... d safety in clinical practice.
@en
prefLabel
Formulation substitution and o ...... d safety in clinical practice.
@ast
Formulation substitution and o ...... d safety in clinical practice.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Formulation substitution and o ...... d safety in clinical practice.
@en
P2093
P304
P31
P356
10.1016/S0002-9149(00)00906-1
P407
P433
P478
P577
P698